Astec Lifesciences Ltd Half Yearly Results

Gross Sales

167.92

204.54

253.64

244.15

384.01

Excise Duty

0

0

0

0

0

Net Sales

167.92

204.54

253.64

244.15

384.01

Other Operating Income

0

0

0

0

0

Other Income

2.92

2.96

2.69

6.36

6.7

Total Income

170.84

207.5

256.33

250.52

390.71

Total Expenditure

233.91

210.17

253.93

226.63

325.28

PBIDT

-63.07

-2.67

2.4

23.89

65.43

Interest

16.38

12.77

12.46

12.28

8.44

PBDT

-79.44

-15.44

-10.06

11.61

56.99

Depreciation

20.74

17.71

18.54

16.56

17.1

Minority Interest Before NP

0

0

0

0

0

Tax

0.02

0.02

0.02

-2.6

2.62

Deferred Tax

-21.93

-7.87

-7.02

1.78

7.54

Reported Profit After Tax

-78.26

-25.29

-21.6

-4.13

29.72

Minority Interest After NP

0.02

0.02

0.02

0.02

0.01

Net Profit after Minority Interest

-78.28

-25.31

-21.62

-4.14

29.71

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-78.28

-25.31

-21.62

-4.14

29.71

EPS (Unit Curr.)

-39.92

0

-11.03

0

15.16

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

19.61

19.61

19.61

19.61

19.6

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-37.55

-1.3

0.94

9.78

17.03

PBDTM(%)

-

-

-

-

-

PATM(%)

-46.6

-12.36

-8.51

-1.69

7.73